Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Stock Forecast

Stock Price Forecast

The 2 analysts that cover Harvard Bioscience stock have a consensus rating of "Buy" and an average price target of $18, which forecasts a 237.08% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $30.

Price Target: $18 (+237.08%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$6.00	$18	$30	$30
Change	+12.36%	+237.08%	+461.80%	+461.80%

Analyst Ratings

The average analyst rating for Harvard Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	0	0	0	0	0	0
Buy	2	2	2	2	2	2
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Bruce D. Jackson Benchmark	Benchmark	Buy Maintains $0.6 → $6	Buy	Maintains	$0.6 → $6	+12.36%	Mar 16, 2026
Bruce D. Jackson Benchmark	Benchmark	Buy Maintains $2 → $0.6	Buy	Maintains	$2 → $0.6	-88.76%	Mar 13, 2026
Bruce D. Jackson Benchmark	Benchmark	Buy Maintains $30 → $20	Buy	Maintains	$30 → $20	+274.53%	Sep 10, 2025
Bruce Jackson Benchmark	Benchmark	Buy Maintains $45 → $30	Buy	Maintains	$45 → $30	+461.80%	May 13, 2025
Paul Knight Keybanc	Keybanc	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Apr 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

94.45M

Increased by 9.13%

from 86.55M

Revenue Next Year

98.43M

Increased by 4.21%

from 94.45M

EPS This Year

0.10

from -12.80

EPS Next Year

0.20

Increased by 110.53%

from 0.10

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	118.90M	113.34M	112.25M	94.14M	86.55M	94.45M	98.43M
Revenue Growth	16.46%	-4.68%	-0.96%	-16.14%	-8.06%	9.13%	4.21%
EPS	-0.10	-2.30	-0.81	-2.85	-12.80	0.10	0.20
EPS Growth	-	-	-	-	-	-	110.53%
Forward PE	-	-	-	-	-	55.11	26.18
No. Analysts	-	-	-	-	-	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	100.4M	101.3M
Avg	94.5M	98.4M
Low	87.8M	94.6M

Revenue Growth

Revenue Growth	2026	2027
High	16.0%	7.3%
Avg	9.1%	4.2%
Low	1.5%	0.1%

EPS Forecast

EPS	2026	2027
High	0.14	0.21
Avg	0.10	0.20
Low	0.06	0.20

EPS Growth

EPS Growth	2026	2027
High	-	116.7%
Avg	-	110.5%
Low	-	102.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.